| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
1 company
Blackwell Kimberly is a Chief Executive Officer at Zentalis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 5,000 | $10.29 | $51,448.00 | +2.0% | +12.1% | -63.8% | |
| Jan 3, 2022 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sale+OE | 1,000 | $83.74 | $83,740.00 | -16.7% | -35.4% | -74.5% | |
| Dec 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sale+OE | 1,000 | $81.84 | $81,840.00 | -16.7% | -31.3% | -71.3% | |
| Nov 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sale+OE | 1,000 | $80.46 | $80,460.00 | -16.7% | -29.5% | -68.4% | |
| Oct 25, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sale+OE | 1,000 | $77.59 | $77,590.00 | -16.7% | -26.9% | -71.0% |